Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-22 Purchase | 2021-06-24 8:55 pm | Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV DF II GP Sarl IHL SA Verelst Luc Naesens Janwillem 10% Owner | 277,777 | $18 | $4,999,986 | 3,536,803 (Direct) | View |
| 2021-06-22 Purchase | 2021-06-24 8:50 pm | Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director | 277,777 | $18 | $4,999,986 | 3,536,803 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-22 Option Award | 2022-02-24 4:57 pm | N/A 2032-02-22 | Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-24 8:55 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV DF II GP Sarl IHL SA Verelst Luc Naesens Janwillem 10% Owner | 14,368,394 | $0 | 3,536,803 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-24 8:50 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director | 14,368,394 | $0 | 3,536,803 (Indirect) | View |
Ownership | 2021-06-17 9:44 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Droia Invest II SCSp Wepaven BV Naesens Janwillem DF II GP Sarl IHL SA Verelst Luc 10% Owner | 0 | $0 | 3,259,025 (Direct) | View |
Ownership | 2021-06-17 9:40 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Naesens Janwillem Director | 0 | $0 | 3,276,273 (Indirect) | View |